相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK
Ming Ding et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives
Derek McCulloch et al.
ONCOTARGETS AND THERAPY (2017)
Optimizing Therapy for Acute Myeloid Leukemia
Holbrook E. Kohrt et al.
Journal of the National Comprehensive Cancer Network (2017)
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acid
Han J. M. P. Verhagen et al.
BLOOD (2016)
All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo
Hayley S. Ma et al.
BLOOD (2016)
Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia
Helena Boutzen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
RAF-1/MEK/ERK pathway regulates ATRA-induced differentiation in acute promyelocytic leukemia cells through C/EBPβ, C/EBPε and PU.1
Xiang-qin Weng et al.
LEUKEMIA RESEARCH (2016)
The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis
Xuejing Shao et al.
SCIENTIFIC REPORTS (2016)
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells
Maria Paola Martelli et al.
BLOOD (2015)
Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells
Hiba El Hajj et al.
BLOOD (2015)
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
Olga Grishina et al.
BMC CANCER (2015)
Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression
Floriana Centritto et al.
EMBO MOLECULAR MEDICINE (2015)
Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid
Gabriele Greve et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients
Michela Tassara et al.
BLOOD (2014)
Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia
Julien Ablain et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Matrine Cooperates with All-Trans Retinoic Acid on Differentiation Induction of All-Trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Cells (NB4-LR1): Possible Mechanisms
Dijiong Wu et al.
PLANTA MEDICA (2014)
Combined staurosporine and retinoic acid induces differentiation in retinoic acid resistant acute promyelocytic leukemia cell lines
Dong-zheng Ge et al.
SCIENTIFIC REPORTS (2014)
Treating acute myeloid leukemia in older adults
Eunice S. Wang
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2013)
Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
Akihiro Tomita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer
Yang Zhang et al.
JOURNAL OF HEPATOLOGY (2013)
Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells
Alejandro Garcia-Regalado et al.
MOLECULAR CANCER (2013)
Bortezomib Sensitizes Human Acute Myeloid Leukemia Cells to All-Trans-Retinoic Acid-Induced Differentiation by Modifying the RARα/STAT1 Axis
Meidan Ying et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Activation of Both Protein Kinase A (PKA) Type I and PKA Type II Isozymes Is Required for Retinoid-Induced Maturation of Acute Promyelocytic Leukemia Cells
Eric Nguyen et al.
MOLECULAR PHARMACOLOGY (2013)
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia
Robert E. Gallagher et al.
BLOOD (2012)
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
R. Pili et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch et al.
CELL (2012)
Combination of Valproic Acid and ATRA Restores RARβ2 Expression and Induces Differentiation in Cervical Cancer through the PI3K/Akt Pathway
D. Feng et al.
CURRENT MOLECULAR MEDICINE (2012)
Effect of all-trans retinoic acid (ATRA) on syndecan-1 expression and its chemoprotective effect in benzo(α) pyrene-induced lung cancer mice model
D. Ramya et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2012)
Inhibition of metastatic lung cancer in C57BL/6 mice by liposome encapsulated all trans retinoic acid (ATRA)
Siddikuzzaman et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Cross Talk between Signaling and Vitamin A Transport by the Retinol-Binding Protein Receptor STRA6
Daniel C. Berry et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
J. Congleton et al.
LEUKEMIA (2012)
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
Tino Schenk et al.
NATURE MEDICINE (2012)
A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK
A. Piskunov et al.
ONCOGENE (2012)
Altered nuclear cofactor switching in retinoic-resistant variants of the PML-RARα oncoprotein of acute promyelocytic leukemia
Mindy Farris et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2012)
Interferon-γ enhances promyelocytic leukemia protein expression in acute promyelocytic cells and cooperates with all-trans-retinoic acid to induce maturation of NB4 and NB4-R1 cells
Pengcheng He et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Retinoids, Retinoic Acid Receptors, and Cancer
Xiao-Han Tang et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer
Margarette Bryan et al.
INVESTIGATIONAL NEW DRUGS (2011)
Inhibition of All-Trans-Retinoic Acid-Induced Proteasome Activation Potentiates the Differentiating Effect of Retinoid in Acute Myeloid Leukemia Cells
Yanfen Fang et al.
MOLECULAR CARCINOGENESIS (2011)
GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells
J. Si et al.
LEUKEMIA (2011)
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA
Alan K. Burnett et al.
BLOOD (2010)
Apoptosis inducing and differentiation enhancement effect of oridonin on the all-trans-retinoic acid-sensitive and -resistant acute promyelocytic leukemia cells
F. Gao et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2010)
Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer
Oscar Arrieta et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oncogenic and cell survival properties of the retinoic acid metabolizing enzyme, CYP26A1
M. Osanai et al.
ONCOGENE (2010)
ZNF423 Is Critically Required for Retinoic Acid-induced Differentiation and Is a Marker of Neuroblastoma Outcome
Sidong Huang et al.
CANCER CELL (2009)
Emerging treatment strategies for acute myeloid leukemia (AML) in the elderly
Andrea Kuendgen et al.
CANCER TREATMENT REVIEWS (2009)
Small Ubiquitin-Like Modifier-2 Modification of Retinoic Acid Receptor-alpha Regulates Its Subcellular Localization and Transcriptional Activity
Li Zhu et al.
ENDOCRINOLOGY (2009)
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
Richard F. Schlenk et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Insoluble, Speckled Cytosolic Distribution of Retinoic Acid Receptor Alpha Protein as a Marker of Hepatic Stellate Cell In Vitro
Yoshihiro Mezaki et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
All-trans- retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RAR alpha
Na Chen et al.
FASEB JOURNAL (2008)
Randomized phase III trial comparing bexarotene (L106949)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I
Rodryg Ramlau et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Lisa Berglund et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells
Rania T. Awwad et al.
ANNALS OF HEMATOLOGY (2008)
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
Annegret Glasow et al.
BLOOD (2008)
Diverse actions of retinoid receptors in cancer prevention and treatment
Nigel P. Mongan et al.
DIFFERENTIATION (2007)
Epigenetic regulation of normal and malignant hematopoiesis
K. L. Rice et al.
ONCOGENE (2007)
Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor
Susana Masia et al.
MOLECULAR ENDOCRINOLOGY (2007)
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
Alan K. Burnett et al.
CANCER (2007)
Down-regulation of the tumor suppressor gene retinoic acid receptor β2 through the phosphoinositide 3-kinase/Akt signaling pathway
Bruno Lefebvre et al.
MOLECULAR ENDOCRINOLOGY (2006)
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial
Donald W. Milligan et al.
BLOOD (2006)
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination moth all-trans retinoic acid in patients with acute myeloid leukemia
A Kuendgen et al.
CANCER (2006)
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia
G Bug et al.
CANCER (2005)
Impaired retinoic acid (RA) signal leads to RARβ2 epigenetic silencing and RA resistance
MQ Ren et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro
Le-Min Lin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
MT Epping et al.
CELL (2005)
The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer
H Kim et al.
CANCER RESEARCH (2005)
Activation of Rac1 by phosphatidylinositol 3-kinase in vivo:: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells
J Pan et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways
A Glasow et al.
BLOOD (2005)
The co-expression of PML/RARα and AML1/ETO fusion genes is associated with ATRA resistance
RSAE Lima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer
J Abu et al.
LANCET ONCOLOGY (2005)
Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor
T Higuchi et al.
LEUKEMIA RESEARCH (2004)
Combination of all-trans retinoic acid and lithium chloride surmounts a retinoid differentiation block induced by expression of Sc1 and Rbtn2 transcription factors in myeloid leukemia cells
AM Rice et al.
LEUKEMIA RESEARCH (2004)
Nuclear retinoid receptors and the transcription of retinoid-target genes
J Bastien et al.
GENE (2004)
Rapid induction of cAMP/PKA pathway during retinoic acid-induced acute promyelocytic leukemia cell differentiation
Q Zhao et al.
LEUKEMIA (2004)
Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells
M Witcher et al.
BLOOD (2004)
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia
RF Schlenk et al.
LEUKEMIA (2004)
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer
FJ Esteva et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
All-trans retinoic acid in acute promyelocytic leukemia:: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
MS Tallman et al.
BLOOD (2002)
In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia
MC Guillemin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up
G Avvisati et al.
BLOOD (2002)
Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells
AM Tari et al.
ONCOGENE (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells:: effects on the degradation of RARα and PML-RARα
M Gianni' et al.
BLOOD (2001)
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
SM Lippman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
P Fenaux et al.
LEUKEMIA (2000)
Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells
SM Sirchia et al.
ONCOGENE (2000)
Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML
S Lehmann et al.
LEUKEMIA RESEARCH (2000)
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia
M Michieli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
分享论文
